Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Terminalia chebula {Haritaki} - Staphylococcus aureus subsp. aureus T0131 |
👶
Large-Scale Screening of 239 Traditional Chinese Medicinal Plant Extracts for Their Antibacterial Activities against Multidrug-Resistant Staphylococcus aureus and Cytotoxic Activities. Pathogens (Basel, Switzerland) (Pathogens ) Vol: 9 Issue 3 Pages: Pub: 2020 Mar 4 Epub: 2020 Mar 4 Authors Kim G , Gan RY , Zhang D , Farha AK , Habimana O , Mavumengwana V , Li HB , Wang XH , Corke H , Html Article Publication |
| Terminalia chebula {Haritaki} - Staphylococcus aureus subsp. aureus T0131 |
👶
Antioxidant, antihypertensive, and antibacterial properties of endophytic Pestalotiopsis species from medicinal plants. Canadian journal of microbiology (Can J Microbiol ) Vol: 54 Issue 9 Pages: 769-80 Pub: 2008 Sep Epub: Authors Tejesvi MV , Kini KR , Prakash HS , Subbiah V , Shetty HS , Publication |
| Terminalia chebula {Haritaki} - Staphylococcus aureus subsp. aureus T0131 |
👶
Antibacterial screening of plants used in Iranian folkloric medicine. Fitoterapia (Fitoterapia ) Vol: 75 Issue 2 Pages: 231-5 Pub: 2004 Mar Epub: Authors Bonjar GH , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
